Source: Eur Respir J 2006; 28: 1178-1185
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Hsieh W-Y., Chen M-W., Ho H-T., You T-M., Lu Y-T.. Identification of differentially expressed proteins in human malignant pleural effusions. Eur Respir J 2006; 28: 1178-1185

Member's Comments

No comment yet.

Related content which might interest you: Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Increased expression of angiogenic growth factor stromal cell derived factor-1 (SDF-1/CXCL12) in pleural fluid of patients with lung cancer: preliminary results Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Angiogenesis in preinvasive, early invasive bronchial lesions and micropapillomatosis and correlation with EGF-R expression Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity Year: 2006 A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma Source: Eur Respir J 2010; 36: 1099-1105 Year: 2010 Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Tumor-derived tumor necrosis factor-α promotes Lewis lung cancer-induced malignant pleural effusions in mice Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006 Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis Source: Eur Respir J 2013; 41: 417-424 Year: 2013 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Proliferation controlling intercellular signalling pathways in human pleural malignant mesothelioma Source: Annual Congress 2007 - Pleural malignancy Year: 2007 WFDC2 (HE4) and SLPI are differentially expressed in normal and diseased human lung and in lung cancer Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Expression of tumor necrosis factor receptor 2 in human non-small cell lung cancer and its role as a potential prognostic biomarker Source: International Congress 2019 – Biology of lung cancer Year: 2019 Expression of protein onkological marker onkoprobe in peripheral blood in cases of tracheal invasion and lung metastases of thyroid carcinoma Source: Eur Respir J 2002; 20: Suppl. 38, 466s Year: 2002 Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis Source: Eur Respir J 2012; 39: 1171-1180 Year: 2012 Epidermal growth factor receptor expression in pre-invasive and early invasive bronchial lesions Source: Eur Respir J 2003; 21: 611-615 Year: 2003 Vitronectin expression in primary lung cancer Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 Clinical features associated with epidermal growth factor receptor and K-RAS gene mutations in non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 811s Year: 2006 Characteristics of common and uncommon epidermal growth factor receptros gene mutations in patients with non small cell lung cancer Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Evolution of microRNA expression during human bronchial squamous carcinogenesis Source: Eur Respir J 2009; 33: 352-359 Year: 2009